TAKQT78Takeda Pharmaceutical Company Limited·NYSE
20.83-0.19%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 29, 20266-KForeign issuer report
Oct 29, 20266-KForeign issuer report
Sep 15, 20264Statement of changes in beneficial ownership
Sep 14, 20266-KForeign issuer report
Sep 10, 2026144Notice of proposed sale of restricted securities
Sep 03, 20264Statement of changes in beneficial ownership
Sep 02, 2026144Notice of proposed sale of restricted securities
Aug 31, 20266-KForeign issuer report
Aug 21, 20264Statement of changes in beneficial ownership
Aug 19, 2026144Notice of proposed sale of restricted securities
Aug 19, 20264Statement of changes in beneficial ownership
Aug 14, 2026144Notice of proposed sale of restricted securities
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership